Protaryx Medical Receives FDA 510(k) Clearance for Its Breakthrough Transseptal Puncture Device

Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart procedures, today announced that it has received 510 (k) clearance from ...
Yahoo Finance

Protaryx Medical completes first-in-human trial of transseptal puncture device

US-based Protaryx Medical has completed a first-in-human trial of its transseptal puncture (TSP) device. The company’s trial enrolled five patients, with the TSP procedure carried out using its device ...
MassDevice

Protaryx earns FDA nod for transseptal puncture device

Protaryx Medical announced that it received FDA 510(k) clearance for its proprietary Transseptal Puncture Device.
Business Wire

Protaryx Medical Achieves Milestone with Successful Completion of First-in-Human Study of an Innovative Transseptal Puncture Technology

BALTIMORE--(BUSINESS WIRE)--Protaryx Medical, a pioneer in medical device innovation, is proud to announce the successful completion of its First-in-Human (FIH) study, demonstrating the transformative ...
Yahoo Finance

Protaryx Medical Submits 510(k) Application for Its Next-Generation Transseptal Puncture Device

BALTIMORE, October 24, 2025--(BUSINESS WIRE)--Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart procedures, today ...
Medscape

Transseptal Approach Shields Brain During Ablation

The occurrence of acute brain lesions was lower with a transseptal puncture than with a conventional retrograde aortic approach in patients undergoing left ventricular catheter ablation, with no ...